Targeting lung attacks.

PubWeight™: 1.53‹?› | Rank: Top 4%

🔗 View Article (PMID 21398372)

Published in Thorax on March 11, 2011

Authors

J Mark FitzGerald

Articles by these authors

Does this dyspneic patient in the emergency department have congestive heart failure? JAMA (2005) 6.14

Adult Asthma Consensus Guidelines update 2003. Can Respir J (2004) 3.61

Mepolizumab treatment in patients with severe eosinophilic asthma. N Engl J Med (2014) 3.50

Delay in diagnosis among hospitalized patients with active tuberculosis--predictors and outcomes. Am J Respir Crit Care Med (2002) 3.10

Economic burden of asthma: a systematic review. BMC Pulm Med (2009) 3.10

Effects of an anti-TSLP antibody on allergen-induced asthmatic responses. N Engl J Med (2014) 2.53

Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries. Value Health (2005) 2.32

Reduction of morbidity and mortality by statins, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers in patients with chronic obstructive pulmonary disease. J Am Coll Cardiol (2006) 1.91

Statins in COPD: a systematic review. Chest (2009) 1.82

Respiratory disease associated with solid biomass fuel exposure in rural women and children: systematic review and meta-analysis. Thorax (2011) 1.80

Risk factors and outcomes associated with chronic obstructive pulmonary disease exacerbations requiring hospitalization. Can Respir J (2009) 1.70

Cost-effectiveness of continuous positive airway pressure therapy for moderate to severe obstructive sleep apnea/hypopnea. Arch Intern Med (2006) 1.68

Risk factors of hospitalization and readmission of patients with COPD exacerbation--systematic review. Int J Chron Obstruct Pulmon Dis (2007) 1.67

A guide to the translation of the Global Initiative for Asthma (GINA) strategy into improved care. Eur Respir J (2012) 1.39

The value of thoracic computed tomography scans in clinical diagnosis: a prospective study. Can Respir J (2006) 1.39

Dispensation of long-acting β agonists with or without inhaled corticosteroids, and risk of asthma-related hospitalisation: a population-based study. Thorax (2013) 1.39

The lack of association between bacille Calmette-Guerin vaccination and clustering of Aboriginals with tuberculosis in western Canada. Can Respir J (2005) 1.38

Implementing practice guidelines: a workshop on guidelines dissemination and implementation with a focus on asthma and COPD. Can Respir J (2006) 1.32

Intake of selenium in the prevention of prostate cancer: a systematic review and meta-analysis. Cancer Causes Control (2005) 1.27

Associations of ambient air pollution with chronic obstructive pulmonary disease hospitalization and mortality. Am J Respir Crit Care Med (2013) 1.24

Management of acute asthma in adults in the emergency department: nonventilatory management. CMAJ (2009) 1.24

Asthma control in Canada: no improvement since we last looked in 1999. Can Fam Physician (2007) 1.24

Management of acute asthma in adults in the emergency department: assisted ventilation. CMAJ (2009) 1.16

Predictors of clustering of tuberculosis in Greater Vancouver: a molecular epidemiologic study. CMAJ (2002) 1.12

Does this patient with liver disease have cirrhosis? JAMA (2012) 1.09

Trends in asthma-related direct medical costs from 2002 to 2007 in British Columbia, Canada: a population based-cohort study. PLoS One (2012) 1.05

The revised 2014 GINA strategy report: opportunities for change. Curr Opin Pulm Med (2015) 1.00

Randomized trial of problem-based versus didactic seminars for disseminating evidence-based guidelines on asthma management to primary care physicians. J Contin Educ Health Prof (2004) 0.98

Vocal cord dysfunction in bronchial asthma. A review article. J Asthma (2014) 0.96

The validity of generic and condition-specific preference-based instruments: the ability to discriminate asthma control status. Qual Life Res (2008) 0.94

The risk of death associated with delayed coronary artery bypass surgery. BMC Health Serv Res (2006) 0.94

Technology, governance and patient safety: systems issues in technology and patient safety. Int J Med Inform (2006) 0.92

Do longer delays for coronary artery bypass surgery contribute to preoperative mortality in less urgent patients? Med Care (2006) 0.92

Bronchodilator responsiveness and reported respiratory symptoms in an adult population. PLoS One (2013) 0.89

Future impact of various interventions on the burden of COPD in Canada: a dynamic population model. PLoS One (2012) 0.88

Decreased miR-192 expression in peripheral blood of asthmatic individuals undergoing an allergen inhalation challenge. BMC Genomics (2012) 0.87

TNFα antagonists for acute exacerbations of COPD: a randomised double-blind controlled trial. Thorax (2012) 0.86

Ten-Year Trends in Direct Costs of COPD: A Population-Based Study. Chest (2015) 0.86

Cost-effectiveness of LTBI treatment for TB contacts in British Columbia. Value Health (2008) 0.85

Factors associated with tuberculin conversion in Canadian microbiology and pathology workers. Am J Respir Crit Care Med (2002) 0.84

Influence of current or former smoking on asthma management and control. Can Respir J (2008) 0.83

Inhaled corticosteroids and the risk of fractures in older adults: a systematic review and meta-analysis. Drug Saf (2008) 0.81

Levofloxacin treatment of active tuberculosis and the risk of adverse events. Chest (2005) 0.81

Budesonide/formoterol as maintenance and reliever treatment compared to fixed dose combination strategies - a Canadian economic evaluation. Can J Clin Pharmacol (2008) 0.81

Gene-metabolite expression in blood can discriminate allergen-induced isolated early from dual asthmatic responses. PLoS One (2013) 0.80

Patient preference for latent tuberculosis infection preventive treatment: a discrete choice experiment. Value Health (2011) 0.78

Does antibiotic exposure during infancy lead to development of asthma? A systematic review and metaanalysis. 2006. Chest (2009) 0.78

Effectiveness of educational interventions on asthma self-management in Punjabi and Chinese asthma patients: a randomized controlled trial. J Asthma (2012) 0.76

Broadening the therapeutic options in acute asthma. Am J Respir Crit Care Med (2003) 0.75

Asthma worsenings: approaches to prevention and management from the Asthma Worsenings Working Group. Can Respir J (2009) 0.75

A quantitative benefit-risk analysis of isoniazid for treatment of latent tuberculosis infection using incremental benefit framework. Value Health (2013) 0.75

Reflections. Can Respir J (2013) 0.75

Case 22-2004: a 30-year-old woman with a pericardial effusion. N Engl J Med (2004) 0.75

Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trial. Trials (2014) 0.75

Network vs. pairwise meta-analyses: a case study of the impact of an evidence-synthesis paradigm on value of information outcomes. Pharmacoeconomics (2014) 0.75

CLINICAL PROBLEM-SOLVING. A Surprising Cause of Chronic Cough. N Engl J Med (2015) 0.75

President's page. What a year! Can Respir J (2014) 0.75

Influences of Socioeconomic Status on Costs of Asthma Under Universal Health Coverage. Med Care (2016) 0.75

Republished editorial: Targeting lung attacks. Postgrad Med J (2011) 0.75

The Canadian Thoracic Society and the Canadian Respiratory Research Network: Something worth celebrating! Can Respir J (2014) 0.75

A framework for achieving better asthma control: introducing two new series in the journal. Int J Tuberc Lung Dis (2006) 0.75

Asthma. Clin Evid (2002) 0.75

Asthma. Clin Evid (2002) 0.75